Weyerhaeuser Company (WY) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Weyerhaeuser Company on May 20, 2026, covering events occurring on May 14 and May 15, 2026. The filing addresses corporate governance matters, specifically the amendment of a deferred compensation plan and the results of the Annual Meeting of Shareholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate actions rather than financial performance metrics.
Material Changes and Corporate Actions
- Deferred Compensation Plan Amendment: On May 14, 2026, the Company amended and restated its 2023 Deferred Compensation Plan. The primary change eliminates the premium previously credited to stock equivalent deferrals. This amendment applies to amounts earned in 2027 and subsequent years.
- Annual Meeting Results: The Annual Meeting was held on May 15, 2026. Of 721,042,609 shares entitled to vote, 661,779,414 were represented.
Shareholder Voting Outcomes
| Proposal | Outcome | Key Vote Counts (For / Against) |
|---|---|---|
| 1. Election of 11 Directors | Approved | Varied by nominee (e.g., Rick Beckwitt: 601.6M For / 1.8M Against) |
| 2. Advisory Vote on Executive Compensation | Approved | 571,085,106 For / 31,062,169 Against |
| 3. Ratification of KPMG as Auditors | Approved | 627,597,889 For / 33,482,606 Against |
Notable Voting Data: Several director nominees received significant "Against" votes, including Nicole W. Piasecki (40.1M against) and Kim Williams (36.7M against), while others like Al Monaco received fewer than 5M against votes. Broker non-votes totaled 55,557,661 for director elections.
Outlook and Risks
The filing does not contain management commentary on future financial guidance, risks, or contingencies. The next Annual Meeting of Shareholders is scheduled for May 14, 2027.
Investor Verification Checklist
- Review the full text of the amended 2026 Deferred Compensation Plan (Exhibit 10.1) to understand the specific impact of removing the stock equivalent premium on executive retention and compensation costs.
- Analyze the significant "Against" votes for specific director nominees (Piasecki, Williams, Holley, Emmert) to assess potential shareholder activism or governance concerns.
- Verify the Company's upcoming 10-K or 10-Q filings for the actual financial performance metrics not included in this 8-K.